INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2019-03-04 ms3309476956082021

投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费

83 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2019-03-04 ms1660087976288132

投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费

78 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2018-11-03 1208f56dm56(暂无昵称)

终于接收了！

251 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2018-04-19 医路阳光

刚刚也投了一篇很期待

303 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2018-03-03 1dd96cb3m86(暂无匿称)

后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表:
第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!

188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!

238 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2017-12-09 1dd96cb3m86(暂无匿称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!

314 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2017-11-14 萍生我自知

审稿速度:1.0 | 投稿命中率:25.0
经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了

287 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2017-08-26 1dd96cb3m86(暂无匿称)

临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表:
这篇杂志倾向于临床方面的么

189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么

273 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2017-07-29 1891f64bccm

这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表:
6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？

186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？

324 0

[GetPortalCommentsPageByObjectIdResponse(id=850054, encodeId=7ec88500543d, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Mon Mar 04 21:52:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850053, encodeId=6cc585005379, content=投稿后1个月通知大修，大修补实验修稿耗时3个月，一修resubmit后1个月再次通知补试验，耗时近2个月后二修修回，1个月后通知许三修，三修耗时1个半月，近3周后通知录用，文章draft online，2周后接到pdf校对稿，校对后2周文章校对的正式pdf online。从投稿到正式pdfonline出版近11个月，没有版面费，没有审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Mon Mar 04 21:51:31 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562687, encodeId=a9db56268e62, content=终于接收了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b52d2189712, createdName=1208f56dm56(暂无昵称), createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555176, encodeId=206e5551e6b2, content=刚刚也投了一篇很期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=303, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er7eXxSuREA09u2EO0sakj11jniaWnR8ztkrV3TRJKibEEKQQz1ndoc8P9EpGdw6GPfZ1PXtplOCtKw/132, createdBy=fe9f2333193, createdName=医路阳光, createdTime=Thu Apr 19 14:15:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553216, encodeId=d6575532165f, content=后面改投绿皮接受-!188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=188****8186(暂无匿称) 2017-12-09 22:31:00 发表: 第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Mar 03 00:00:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549870, encodeId=417d5498e07f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第二次投稿.肝癌sbrt.由于前不久红皮刚刚发表一篇类似的文章.with editor 8天.没有送外审.可惜!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Dec 09 22:31:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549198, encodeId=78e35491988d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：要$75审稿费，不是版面费，2周被拒，审稿人给的意见很中肯，很专业，连空格这种错误都会指出，我就当润笔费了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993f2004533, createdName=萍生我自知, createdTime=Tue Nov 14 20:49:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545922, encodeId=e39754592233, content=临床放疗.物理.基础都有189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, beContent=189****1090暂无昵称 2017-07-29 00:00:00 发表: 这篇杂志倾向于临床方面的么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=273, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Aug 26 00:00:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544915, encodeId=252e54491596, content=这篇杂志倾向于临床方面的么186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=186****9961(暂无匿称) 2017-07-24 08:55:00 发表: 6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9a62099967, createdName=1891f64bccm, createdTime=Sat Jul 29 00:00:00 CST 2017, time=2017-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544734, encodeId=470e544e3425, content=6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa8a1674471, createdName=1de1c595m61(暂无匿称), createdTime=Mon Jul 24 08:55:00 CST 2017, time=2017-07-24, status=1, ipAttribution=)]

2017-07-24 1de1c595m61(暂无匿称)

6月7日投稿，7月18日变成under review，21日就成了dicision depending，是不是没希望了？

424 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务